Literature DB >> 27121329

Molecular epidemiology, genotype-phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria.

Luis Aldámiz-Echevarría1, Marta Llarena1, María A Bueno2, Jaime Dalmau3, Isidro Vitoria3, Ana Fernández-Marmiesse4, Fernando Andrade1, Javier Blasco5, Carlos Alcalde6, David Gil7, María C García8, Domingo González-Lamuño9, Mónica Ruiz10, María A Ruiz11, Luis Peña-Quintana12, David González13, Felix Sánchez-Valverde14, Lourdes R Desviat15, Belen Pérez15, María L Couce4.   

Abstract

Phenylketonuria (PKU), the most common inborn error of amino acid metabolism, is caused by mutations in the phenylalanine-4-hydroxylase (PAH) gene. This study aimed to assess the genotype-phenotype correlation in the PKU Spanish population and the usefulness in establishing genotype-based predictions of BH4 responsiveness in our population. It involved the molecular characterization of 411 Spanish PKU patients: mild hyperphenylalaninemia non-treated (mild HPA-NT) (34%), mild HPA (8.8%), mild-moderate (20.7%) and classic (36.5%) PKU. BH4 responsiveness was evaluated using a 6R-BH4 loading test. We assessed genotype-phenotype associations and genotype-BH4 responsiveness in our population according to literature and classification of the mutations. The mutational spectrum analysis showed 116 distinct mutations, most missense (70.7%) and located in the catalytic domain (62.9%). The most prevalent mutations were c.1066-11G>A (9.7%), p.Val388Met (6.6%) and p.Arg261Gln (6.3%). Three novel mutations (c.61-13del9, p.Ile283Val and p.Gly148Val) were reported. Although good genotype-phenotype correlation was observed, there was no exact correlation for some genotypes. Among the patients monitored for the 6R-BH4 loading test: 102 were responders (87, carried either one or two BH4-responsive alleles) and 194 non-responders (50, had two non-responsive mutations). More discrepancies were observed in non-responders. Our data reveal a great genetic heterogeneity in our population. Genotype is quite a good predictor of phenotype and BH4 responsiveness, which is relevant for patient management, treatment and follow-up.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27121329     DOI: 10.1038/jhg.2016.38

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  39 in total

1.  Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population.

Authors:  Rosa Gassió; Rafael Artuch; Maria Antonia Vilaseca; Eugenia Fusté; Cristina Boix; Anna Sans; Jaume Campistol
Journal:  Dev Med Child Neurol       Date:  2005-07       Impact factor: 5.449

2.  Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: molecular survey by regions.

Authors:  L R Desviat; B Pérez; A Gámez; A Sánchez; M J García; M Martínez-Pardo; C Marchante; D Bóveda; A Baldellou; J Arena; P Sanjurjo; A Fernández; M L Cabello; M Ugarte
Journal:  Eur J Hum Genet       Date:  1999-04       Impact factor: 4.246

3.  Phenylalanine hydroxylase deficiency: molecular epidemiology and predictable BH4-responsiveness in South Portugal PKU patients.

Authors:  Isabel Rivera; Dina Mendes; Ângela Afonso; Madalena Barroso; Ruben Ramos; Patrícia Janeiro; Anabela Oliveira; Ana Gaspar; Isabel Tavares de Almeida
Journal:  Mol Genet Metab       Date:  2011-07-31       Impact factor: 4.797

Review 4.  Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria.

Authors:  Kimberlee Michals-Matalon
Journal:  Expert Opin Investig Drugs       Date:  2008-02       Impact factor: 6.206

Review 5.  Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.

Authors:  Caroline Heintz; Richard G H Cotton; Nenad Blau
Journal:  Hum Mutat       Date:  2013-05-01       Impact factor: 4.878

Review 6.  Molecular genetics and diagnosis of phenylketonuria: state of the art.

Authors:  Nenad Blau; Nan Shen; Carla Carducci
Journal:  Expert Rev Mol Diagn       Date:  2014-05-31       Impact factor: 5.225

Review 7.  Phenylketonuria mutations in Europe.

Authors:  Johannes Zschocke
Journal:  Hum Mutat       Date:  2003-04       Impact factor: 4.878

8.  Molecular epidemiology and genotype-phenotype correlation in phenylketonuria patients from South Spain.

Authors:  María A Bueno; Domingo González-Lamuño; Carmen Delgado-Pecellín; Luís Aldámiz-Echevarría; Belén Pérez; Lourdes R Desviat; María L Couce
Journal:  J Hum Genet       Date:  2013-03-21       Impact factor: 3.172

9.  Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.

Authors:  Marcel R Zurflüh; Johannes Zschocke; Martin Lindner; François Feillet; Céline Chery; Alberto Burlina; Raymond C Stevens; Beat Thöny; Nenad Blau
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

10.  Whole-exome sequencing reveals diverse modes of inheritance in sporadic mild to moderate sensorineural hearing loss in a pediatric population.

Authors:  Nayoung K D Kim; Ah Reum Kim; Kyung Tae Park; So Young Kim; Min Young Kim; Jae-Yong Nam; Se Joon Woo; Seung-Ha Oh; Woong-Yang Park; Byung Yoon Choi
Journal:  Genet Med       Date:  2015-02-26       Impact factor: 8.822

View more
  9 in total

1.  Characterization of Phenyalanine Hydroxylase Gene Mutations in Chilean PKU Patients.

Authors:  V Hamilton; L Santa María; K Fuenzalida; P Morales; L R Desviat; M Ugarte; B Pérez; J F Cabello; V Cornejo
Journal:  JIMD Rep       Date:  2017-12-30

2.  Spectrum of PAH gene mutations in 1547 phenylketonuria patients from Iran: a comprehensive systematic review.

Authors:  Reza Alibakhshi; Aboozar Mohammadi; Nader Salari; Sahand Khamooshian; Mohsen Kazeminia; Keivan Moradi
Journal:  Metab Brain Dis       Date:  2021-02-24       Impact factor: 3.584

3.  Phenylketonuria in Portugal: Genotype-phenotype correlations using molecular, biochemical, and haplotypic analyses.

Authors:  Filipa Ferreira; Luísa Azevedo; Raquel Neiva; Carmen Sousa; Helena Fonseca; Ana Marcão; Hugo Rocha; Célia Carmona; Sónia Ramos; Anabela Bandeira; Esmeralda Martins; Teresa Campos; Esmeralda Rodrigues; Paula Garcia; Luísa Diogo; Ana Cristina Ferreira; Silvia Sequeira; Francisco Silva; Luísa Rodrigues; Ana Gaspar; Patrícia Janeiro; António Amorim; Laura Vilarinho
Journal:  Mol Genet Genomic Med       Date:  2021-01-19       Impact factor: 2.183

4.  Genotype-phenotype correlations and BH4 estimated responsiveness in patients with phenylketonuria from Rio de Janeiro, Southeast Brazil.

Authors:  Eduardo Vieira Neto; Francisco Laranjeira; Dulce Quelhas; Isaura Ribeiro; Alexandre Seabra; Nicole Mineiro; Lilian M Carvalho; Lúcia Lacerda; Márcia G Ribeiro
Journal:  Mol Genet Genomic Med       Date:  2019-03-03       Impact factor: 2.183

5.  Expanded Newborn Screening for Inborn Errors of Metabolism by Tandem Mass Spectrometry in Suzhou, China: Disease Spectrum, Prevalence, Genetic Characteristics in a Chinese Population.

Authors:  Ting Wang; Jun Ma; Qin Zhang; Ang Gao; Qi Wang; Hong Li; Jingjing Xiang; Benjing Wang
Journal:  Front Genet       Date:  2019-10-29       Impact factor: 4.599

6.  An Updated PAH Mutational Spectrum of Phenylketonuria in Mexican Patients Attending a Single Center: Biochemical, Clinical-Genotyping Correlations.

Authors:  Marcela Vela-Amieva; Miguel Angel Alcántara-Ortigoza; Isabel Ibarra-González; Ariadna González-Del Angel; Liliana Fernández-Hernández; Sara Guillén-López; Lizbeth López-Mejía; Rosa Itzel Carrillo-Nieto; Leticia Belmont-Martínez; Cynthia Fernández-Lainez
Journal:  Genes (Basel)       Date:  2021-10-23       Impact factor: 4.096

7.  Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region.

Authors:  Álvaro Martín-Rivada; Laura Palomino Pérez; Pedro Ruiz-Sala; Rosa Navarrete; Ana Cambra Conejero; Pilar Quijada Fraile; Ana Moráis López; Amaya Belanger-Quintana; Elena Martín-Hernández; Marcello Bellusci; Elvira Cañedo Villaroya; Silvia Chumillas Calzada; María Teresa García Silva; Ana Bergua Martínez; Sinziana Stanescu; Mercedes Martínez-Pardo Casanova; Miguel L F Ruano; Magdalena Ugarte; Belén Pérez; Consuelo Pedrón-Giner
Journal:  JIMD Rep       Date:  2022-01-27

8.  Spectrum of Phenylalanine Hydroxylase Gene Mutations in Hamadan and Lorestan Provinces of Iran and Their Associations with Variable Number of Tandem Repeat Alleles.

Authors:  Reza Alibakhshi; Keivan Moradi; Mostafa Biglari; Samaneh Shafieenia
Journal:  Iran J Med Sci       Date:  2018-05

9.  Mutation analysis of the PAH gene in phenylketonuria patients from Rio de Janeiro, Southeast Brazil.

Authors:  Eduardo Vieira Neto; Francisco Laranjeira; Dulce Quelhas; Isaura Ribeiro; Alexandre Seabra; Nicole Mineiro; Lilian D M Carvalho; Lúcia Lacerda; Márcia G Ribeiro
Journal:  Mol Genet Genomic Med       Date:  2018-05-10       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.